Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
MANE
STRONG SELLVeradermics, Incorporated · Healthcare · United States · $4.6B · Avg Vol: $82M/d
8
StockRankGet insider-trade alerts
Q
35
V
23
M
24
P/E (TTM)
—
ROE
—
D/E
0.0x
Dividend %
—
Loading 1Y...
PRICE (1Y)+16.0%
SMA 50SMA 200
Close
$111.42
RSI (14)
46.8
SCORE BREAKDOWN
Quality
35
ROIC
-48.8%15.8
ROE
—N/A
GP/Assets
—N/A
Op. Margin
0.0%41.3
FCF/Assets
-46.9%5.9
Piotroski
239.0
Int. Cover
—N/A
D/E Ratio
0.00x95.6
Current Ratio
59.12x99.3
Value
23
P/E (TTM)
—N/A
EV/EBITDA
—N/A
P/FCF
—N/A
P/B
10.5x10.7
P/S
—N/A
Div Yield
—N/A
Momentum
24
52W High %
—N/A
RS 6M
—N/A
SMA 50/200
—N/A
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
-15%16.0
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$4.6B
P/E (Forward)
-35.9x
Gross Margin
—
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of MANE are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| MANE | Veradermics, Incorporated(you) | $4.6B | 8 | STRONG SELL |
| PBLS | Parabilis Medicines, Inc. | $3.8B | 5 | STRONG SELL |
| CELC | Celcuity Inc. | $4.0B | 14 | STRONG SELL |
| SRRK | Scholar Rock Holding Corporation | $5.7B | 15 | STRONG SELL |
| GPCR | Structure Therapeutics Inc. | $3.5B | 15 | STRONG SELL |
| VERA | Vera Therapeutics, Inc. | $2.5B | 9 | STRONG SELL |
| KLRA | Kailera Therapeutics, Inc. | $2.3B | 9 | STRONG SELL |
| VKTX | Viking Therapeutics, Inc. | $4.0B | 21 | SELL |
| IONS | Ionis Pharmaceuticals, Inc. | $9.3B | 6 | STRONG SELL |
| LEGN | Legend Biotech Corporation | $4.3B | 24 | SELL |
Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.5%